Kadry et al. showed that MMP3 activity are elevated in ARDS patients and the inhibition of MMP3 reduces the severity of bacterial lipopolysaccharide-induced ARDS in animal models8. This evidence concerns the gene MMP3 and acute respiratory distress syndrome.